What it sells
Silvia Bio profiles mammalian cell performance in biomanufacturing to find yield bottlenecks, then supplies precision media additives that raise product titre and critical quality attributes.
Business model breakdown
Workflow: what inputs become what output?
Identify bottlenecks with proprietary cell profiling, then fix them with precision media additives.
Distribution: how it reaches customers
Service platform with case studies; contact the team via Get in touch.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-15 | — | £3M | Northern Gritstone | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-29.